BRIDGE PHARMA

DEAD

Serial Number

97978608

Owner

Bridgewest International Holdings LLC

Attorney

Lisel M. Ferguson

Filing Date

Jan 18, 2023

Add to watchlist:

No watchlists yet

+ Create New Watchlist

View on USPTO

BRIDGE PHARMA Trademark

Serial Number: 97978608

BRIDGE PHARMA is a trademark filed by Bridgewest International Holdings LLC on January 18, 2023. The trademark is classified under Class 5 (Pharmaceuticals), Class 40 (Treatment & Processing). The application is currently no longer active.

Trademark Classes

Class 5 - Pharmaceuticals

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Class 40 - Treatment & Processing

Treatment of materials

Owner Contact Info

Bridgewest International Holdings LLC (10 trademarks)

701 Brickell Avenue, Suite 1490
Miami, FL 33131

Entity Type: 16

Legal Representation

Attorney of Record

Lisel M. Ferguson

1,233 trademarks filed View all →

Correspondence Address

Lisel M. Ferguson RIMON PC

1655 Fairview Ave., Ste 102

Boise, ID 83702

United States

Trademark Details

Filing Date

January 18, 2023

Registration Date

Not Registered

Published for Opposition

September 10, 2024

Goods & Services

Pharmaceutical products for use by humans, namely, sterile injectable pharmaceutical preparations for the treatment of dehydration, low potassium levels, bleeding, infection, and pain

Custom manufacture of therapeutics, disinfectants, diluents, and vaccines for the treatment of dehydrations, low potassium levels, bleeding, infection and pain

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED

Dec 8, 2025 MAB6

ABANDONMENT - NO USE STATEMENT FILED

Dec 8, 2025 ABN6

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED

Dec 8, 2025 MAB6

ABANDONMENT - NO USE STATEMENT FILED

Dec 8, 2025 ABN6

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Oct 9, 2025 EXRA

SOU EXTENSION 1 GRANTED

Oct 8, 2025 EX1G

SOU EXTENSION 1 FILED

Apr 25, 2025 EXT1

TEAS CHANGE OF CORRESPONDENCE RECEIVED

Apr 25, 2025 TCCA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

Apr 25, 2025 ARAA

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

Apr 25, 2025 REAP

SOU TEAS EXTENSION RECEIVED

Apr 25, 2025 EEXT

TEAS CHANGE OF CORRESPONDENCE RECEIVED

Mar 31, 2025 TCCA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

Mar 31, 2025 ARAA

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

Mar 31, 2025 REAP

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Nov 5, 2024 NOAM

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Sep 10, 2024 NPUB

PUBLISHED FOR OPPOSITION

Sep 10, 2024 PUBO

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Aug 21, 2024 NONP

APPROVED FOR PUB - PRINCIPAL REGISTER

Aug 7, 2024 CNSA

DIVISIONAL PROCESSING COMPLETE

Aug 7, 2024 DPCC

CASE ASSIGNED TO INTENT TO USE PARALEGAL

Aug 6, 2024 AITU

APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED

Jun 7, 2024 XELG

APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED

Jun 7, 2024 XELR

DIVISIONAL REQUEST RECEIVED

May 14, 2024 DRRR

TEAS REQUEST TO DIVIDE RECEIVED

May 14, 2024 ERTD

NOTIFICATION OF FINAL REFUSAL EMAILED

Mar 7, 2024 GNFN

FINAL REFUSAL E-MAILED

Mar 7, 2024 GNFR

FINAL REFUSAL WRITTEN

Mar 7, 2024 CNFR

TEAS/EMAIL CORRESPONDENCE ENTERED

Jan 25, 2024 TEME

CORRESPONDENCE RECEIVED IN LAW OFFICE

Jan 24, 2024 CRFA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Jan 24, 2024 TROA

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Oct 25, 2023 GNRN

NON-FINAL ACTION E-MAILED

Oct 25, 2023 GNRT

NON-FINAL ACTION WRITTEN

Oct 25, 2023 CNRT

ASSIGNED TO EXAMINER

Oct 16, 2023 DOCK

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Jan 25, 2023 NWOS

NEW APPLICATION ENTERED

Jan 21, 2023 NWAP

Related Trademarks

More from this Owner

ORA VILLAS COLLECTION

ORA

ORA VILLAS COLLECTION

ORA

BRIDGE PHARMA

More in Same Class

FOSFO-MED